Rothschild Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.36M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.88M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$3.88M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.79M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.87M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.37M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$5.02M |
| 4 |
SPDR Gold Trust
GLD
|
+$5M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.65% |
| 2 | Communication Services | 14.74% |
| 3 | Financials | 9.22% |
| 4 | Industrials | 8.1% |
| 5 | Energy | 5.91% |
Similar funds
Rothschild Capital Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Rothschild Capital Partners held 59 positions worth $255M, up 9.7% from $232M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Rothschild Capital Partners withdrew a net $9.77M in Q4 2017, closing 10 positions and reducing 27 holdings. Its most notable exit was Celgene Corp, an estimated $6.87M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 41% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Rothschild Capital Partners opened a new position in State Street SPDR S&P Regional Banking ETF worth $3.97M.
- Rothschild Capital Partners's largest Q4 2017 buy was State Street SPDR S&P Regional Banking ETF: 67,460 shares worth $3.97M.
- Rothschild Capital Partners added most to State Street Financial Select Sector SPDR ETF in Q4 2017, an estimated $4.36M increase.
- Rothschild Capital Partners's biggest Q4 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $5.37M.
- Rothschild Capital Partners fully exited Celgene Corp in Q4 2017, selling an estimated $6.87M.
- Rothschild Capital Partners's ten largest holdings make up 56% of its $255M portfolio in Q4 2017.
- Rothschild Capital Partners opened 8 new positions and closed 10 in Q4 2017.
- Rothschild Capital Partners's portfolio value rose 9.7% quarter-over-quarter to $255M.
Based on Rothschild Capital Partners's 13F filing for Q4 2017, filed 31 Jan 2018.